Heyholder
‹ Activism Filings

ENZYCHEM LIFESCIENCES CORPORATION Q3 operating loss of KRW 4.5 billion on revenue of KRW 20.2 billion

ENZYCHEM LIFESCIENCES CORPORATION· Periodic Report

AI summary · Not investment advice

In Q3, the company sold KRW 20.2 billion of goods and lost KRW 4.5 billion from its main business, versus a KRW 3.7 billion loss a year earlier.

Operating profit · 3 months

KRW -4.5 billion

Key facts

Revenue (3 months)
KRW 20.2 billion
Net income (3 months)
KRW -4.0 billion
Period
Q3 (cumulative Jan 1, 2026 ~ Sep 30, 2026)
Revenue (prior-year 3 months)
KRW 16.5 billion
Revenue (year to date)
KRW 58.6 billion
Operating profit (prior-year 3 months)
KRW -3.7 billion
Operating profit (year to date)
KRW -11.8 billion
Net income (prior-year 3 months)
KRW -3.3 billion
Net income (year to date)
KRW -8.7 billion

Commentary

AI commentary · Not investment advice

What happened

Enzychem Lifesciences reported its third-quarter results on a consolidated basis. Sales for the latest 3 months were KRW 20.16 billion. That is 22.4% more than the same period a year earlier and 14.4% less than the previous quarter.

In the company's terms

Operating profit (profit from the core business) for the 3 months was a loss of KRW 4.51 billion. A year earlier, the loss was KRW 3.72 billion. Net income (the final profit after taxes and other items) for the 3 months was a loss of KRW 4.05 billion. A year earlier, the loss was KRW 3.30 billion.

What changes for shareholders

For the cumulative period from January 1 to September 30, sales were KRW 58.60 billion. The operating loss was KRW 11.82 billion. The net loss was KRW 8.71 billion.

Comments

No comments yet

Comments from shareholders will appear here.